Zoledronic Acid after Treatment with Denosumab is Associated with Bone Loss within 1 Year.

J Bone Metab · 2021 · PMC7973401 · PMID 33730783

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Notably however, while our analyses of BMD changes at the lumbar spine and hip did not reach statistical significance, the trends were comparable to previous studies that did achieve statistical significance.[ 15 , 16 ] Measurement of BTMs is also missing from our study, somewhat limiting our interpretation of the results.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.